Therapeutic potential of chimeric amyloid-reactive monoclonal antibody 11-1F4.

Abstract

PURPOSE We had previously reported that certain of our murine (m) antihuman light chain monoclonal antibodies (mAbs) recognized an epitope common to AL and other types of amyloid fibrils. On the basis of this evidence, one such antibody, 11-1F4, was administered to mice bearing AL amyloidomas induced by s.c. injection of human AL extracts. The mAb bound to… (More)

Topics

Cite this paper

@article{Solomon2003TherapeuticPO, title={Therapeutic potential of chimeric amyloid-reactive monoclonal antibody 11-1F4.}, author={Alan Solomon and Deborah T. Weiss and Jonathan S. Wall}, journal={Clinical cancer research : an official journal of the American Association for Cancer Research}, year={2003}, volume={9 10 Pt 2}, pages={3831S-8S} }